statistiche ricercatore

Continente	#
NA - Nord America	550
AS - Asia	338
EU - Europa	174
SA - Sud America	66
AF - Africa	9
Continente sconosciuto - Info sul continente non disponibili	8
OC - Oceania	1
Totale	1.146

Nazione	#
US - Stati Uniti d'America	530
SG - Singapore	125
CN - Cina	76
VN - Vietnam	60
BR - Brasile	53
DE - Germania	42
IT - Italia	30
HK - Hong Kong	22
SE - Svezia	18
GB - Regno Unito	17
FR - Francia	16
IN - India	13
BD - Bangladesh	12
FI - Finlandia	11
RU - Federazione Russa	10
CA - Canada	9
JP - Giappone	9
AR - Argentina	6
TR - Turchia	6
UA - Ucraina	5
BE - Belgio	4
ID - Indonesia	4
PL - Polonia	4
ZA - Sudafrica	4
AT - Austria	3
CR - Costa Rica	3
EC - Ecuador	3
IQ - Iraq	3
LT - Lituania	3
MA - Marocco	3
MX - Messico	3
CO - Colombia	2
CZ - Repubblica Ceca	2
ES - Italia	2
JM - Giamaica	2
JO - Giordania	2
NI - Nicaragua	2
NL - Olanda	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
DZ - Algeria	1
HU - Ungheria	1
IM - Isola di Man	1
KE - Kenya	1
KZ - Kazakistan	1
NP - Nepal	1
OM - Oman	1
PA - Panama	1
PE - Perù	1
RO - Romania	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
TO - Tonga	1
UZ - Uzbekistan	1
VE - Venezuela	1
Totale	1.138

Nome	#
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure	200
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy	185
TB meningitis in HIV-positive patients in Europe and Argentina: Clinical dutcome and factors associated with mortality	175
Predictors of access and response to DAA in a cohort of human immunodeficiency virus/hepatitis C virus co-infected patients in Italy	134
Serious liver events and liver-related deaths in HIV/HCV co-infected patients with diabetes: data from the ICONA Foundation Cohort Study.	121
Evolution and reversibility of renal function after switch from TDF to TAF regimens	118
Low Body Mass Index (BMI) in ART naïve HIV-positive subjects and risk of virologic failure and drug discontinuation: data from the ICONA Foundation cohort.	111
Two years of exposure to elvitegravir/cobicistat/emtricitabine/tenofovir(E/C/FTC/TDF): an overview of the trend in laboratory parameters in clinical practice.	102
Totale	1.146

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	56	0	4	0	1	10	4	0	4	1	7	1	24
2022/2023	65	9	5	6	6	11	7	6	5	4	0	6	0
2023/2024	42	2	5	3	2	0	9	0	5	1	0	0	15
2024/2025	215	2	2	15	10	23	34	1	8	29	25	34	32
2025/2026	631	73	30	49	77	102	46	85	26	54	44	26	19
2026/2027	22	6	16	0	0	0	0	0	0	0	0	0	0
Totale													1.146

SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara